Plexus Announces Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results
Plexus (NASDAQ: PLXS) reported fiscal Q4 (ended Sep 27, 2025) revenue of $1.058B, GAAP diluted EPS of $1.87 and non-GAAP diluted EPS of $2.14. Fiscal 2025 revenue was $4.033B with GAAP EPS $6.26 and non-GAAP EPS $7.43. Q4 free cash flow was $97M; FY2025 free cash flow was $154M. ROIC was 14.6% producing an economic return of 5.7% above WACC. The company repurchased $65M of shares in FY2025 and repurchased $21.5M in Q4; $85M remains under the $100M authorization. Q1 FY2026 guidance: revenue $1.050B–$1.090B and non-GAAP EPS $1.66–$1.81.
Plexus (NASDAQ: PLXS) ha riportato nel quarto fiscale (terminato il 27 settembre 2025) ricavi di $1.058B, EPS diluito GAAP di $1.87 e EPS diluito non-GAAP di $2.14. Il fatturato per l'intero 2025 è stato di $4.033B con EPS GAAP di $6.26 e EPS non-GAAP di $7.43. Il free cash flow del Q4 è stato di $97M; FY2025 free cash flow è stato di $154M. ROIC è stato 14.6%, producendo un ritorno economico di 5.7% al di sopra del WACC. L'azienda ha riacquistato $65M di azioni nell'FY2025 e $21.5M nel Q4; rimangono $85M sotto l'autorizzazione di $100M. Guida per Q1 FY2026: ricavi $1.050B–$1.090B e EPS non-GAAP $1.66–$1.81.
Plexus (NASDAQ: PLXS) reportó ingresos del cuarto trimestre fiscal (terminado el 27 de septiembre de 2025) de $1.058B, BPA diluido GAAP de $1.87 y BPA diluido no-GAAP de $2.14. Los ingresos del año fiscal 2025 fueron de $4.033B con BPA GAAP de $6.26 y BPA no-GAAP de $7.43. El flujo de caja libre del Q4 fue de $97M; el flujo de caja libre FY2025 fue de $154M. ROIC fue 14.6%, generando un retorno económico de 5.7% por encima del WACC. La compañía recompró $65M en acciones en FY2025 y $21.5M en Q4; quedan $85M bajo la autorización de $100M. Guía para Q1 FY2026: ingresos de $1.050B–$1.090B y BPA No-GAAP $1.66–$1.81.
Plexus (NASDAQ: PLXS) 회계연도 4분기 매출은 미달러 10.58억 달러, GAAP 희석 EPS는 1.87 달러, 비GAAP 희석 EPS는 2.14 달러였다. 회계연도 2025년 매출은 미화 40.33억 달러로, GAAP EPS는 6.26 달러, 비GAAP EPS는 7.43 달러이다. 4분기 자유현금흐름은 9700만 달러, FY2025 자유현금흐름은 1.54억 달러였다. ROIC는 14.6%로, WACC를 상회하는 5.7%의 경제적 수익을 창출했다. 회사는 FY2025에 주식 6,500만 달러를, Q4에 2,150만 달러를 재매입했으며, 1억 달러 허용 한도 내 남은 금액은 8,500만 달러다. FY2026 1분기 가이던스: 매출 10.50억–10.90억 달러, 비GAAP EPS 1.66–1.81 달러.
Plexus (NASDAQ : PLXS) a annoncé un chiffre d'affaires du quatrième trimestre fiscal (se terminant le 27 septembre 2025) de 1,058 milliard de dollars, un BPA dilué GAAP de 1,87 $ et un BPA dilué non GAAP de 2,14 $. Le chiffre d'affaires de l'exercice 2025 s'élève à 4,033 milliards de dollars avec un BPA GAAP de 6,26 et un BPA non GAAP de 7,43. Le flux de trésorerie libre du Q4 était de 97 millions de dollars; le flux de trésorerie libre FY2025 était de 154 millions. Le ROIC était de 14,6%, générant un rendement économique de 5,7% au-dessus du WACC. L'entreprise a racheté pour 65 millions de dollars d'actions dans FY2025 et 21,5 millions au Q4; il reste 85 millions sous l'autorisation de 100 millions. Guidance pour Q1 FY2026 : chiffre d'affaires entre 1,050–1,090 milliards de dollars et BPA non GAAP entre 1,66–1,81 dollars.
Plexus (NASDAQ: PLXS) meldete im vierten Quartal des Geschäftsjahres (beendet am 27. September 2025) einen Umsatz von 1,058 Mrd. USD, GAAP bereinigtes dilutes EPS von 1,87 USD und non-GAAP dilutes EPS von 2,14 USD. Der Umsatz des Geschäftsjahres 2025 betrug 4,033 Mrd. USD mit GAAP EPS von 6,26 und non-GAAP EPS von 7,43 USD. Der Freie Cashflow im Q4 lag bei 97 Mio. USD; der freie Cashflow FY2025 betrug 154 Mio. USD. ROIC war 14,6%, was eine wirtschaftliche Rendite von 5,7% über dem WACC ergibt. Das Unternehmen hat im FY2025 Aktien im Wert von 65 Mio. USD zurückgekauft und im Q4 21,5 Mio. USD; es bleiben 85 Mio. USD unter der Genehmigung von 100 Mio. USD. Ausblick Q1 FY2026: Umsatz 1,050–1,090 Mrd. USD und non-GAAP EPS 1,66–1,81 USD.
Plexus (NASDAQ: PLXS) أبلغت عن إيرادات الربع الرابع من السنة المالية المنتهية في 27 سبتمبر 2025 قدرها $1.058B، وربحية السهم المخفّف وفق معايير GAAP قدرها $1.87 ودخل السهم المخفّف غير GAAP قدره $2.14. بلغت إيرادات السنة المالية 2025 $4.033B مع ربحية سهم GAAP قدرها $6.26 وربحية السهم المخفف غير GAAP قدرها $7.43. كان التدفق النقدي الحر للربع الرابع $97M؛ وتدفق النقد الحر للسنة المالية 2025 كان $154M. ROIC بلغ 14.6% محققاً عائداً اقتصادياً قدره 5.7% فوق WACC. قامت الشركة بإعادة شراء أسهم بقيمة $65M في FY2025 و$21.5M في Q4؛ يبقى $85M ضمن تفويض $100M. التوجيه للربع الأول من FY2026: الإيرادات بين $1.050B–$1.090B وربحية السهم المخفف غير GAAP بين $1.66–$1.81 دولار.
Plexus (NASDAQ: PLXS) 报告财年第四季度(截至 2025 年 9 月 27 日)的收入为 $1.058B,GAAP 稀释后每股收益为 $1.87,非 GAAP 稀释后每股收益为 $2.14。2025 财年收入为 $4.033B,GAAP EPS 为 $6.26,非 GAAP EPS 为 $7.43。第四季度自由现金流为 $97M,2025 财年自由现金流为 $154M。ROIC 为 14.6%,实现了高于 WACC 的经济回报 5.7%。公司在 FY2025 回购了 $65M 的股票,在 Q4 回购了 $21.5M;在 1 亿美元授权额度下仍有 $85M 未使用。2026 财年第一季度指引:收入在 $1.050B–$1.090B,非 GAAP 稀释后 EPS 在 $1.66–$1.81。
- Fiscal 2025 revenue of $4.033B
- FY2025 free cash flow of $154M
- ROIC of 14.6% (economic return +5.7% above WACC)
- Generated $941M annualized revenue from 141 new program wins in FY2025
- Share repurchases of $65M in FY2025 with $85M remaining authorization
- Company guidance expects FY2026 free cash flow of ~$100M (down vs FY2025 $154M)
- Europe, Middle East & Africa revenue for FY2025 fell to $440M from $538M (≈18% decline)
- Top 10 customers comprised 49% of Q4 revenue, indicating customer concentration risk
Insights
Plexus delivered above-guidance fiscal 2025 results with revenue of
Plexus reported fiscal 2025 revenue of
Key operational facts: generated quarterly free cash flow of
Dependencies and risks are explicit: top 10 customers represented
Concrete items to watch include actual Q1 fiscal 2026 results against the guidance ranges, execution of planned investments and their impact on margins, and use of remaining share repurchase authorization. Note the earnings conference call scheduled on
NEENAH, WI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal fourth quarter and fiscal year ended September 27, 2025, and guidance for our fiscal first quarter ending January 3, 2026.
- Reports fiscal fourth quarter revenue of
$1.05 8 billion, GAAP operating margin of5.0% and GAAP diluted EPS of$1.87 . - Reports fiscal 2025 revenue of
$4.03 3 billion, GAAP operating margin of5.0% and GAAP diluted EPS of$6.26 . - Reports fiscal fourth quarter non-GAAP operating margin of
5.8% and non-GAAP diluted EPS of$2.14 , excluding$0.27 of stock-based compensation expense. - Reports fiscal 2025 non-GAAP operating margin of
5.9% and non-GAAP diluted EPS of$7.43 , excluding$1.02 of stock-based compensation expense and$0.15 of restructuring and other charges. - Initiates fiscal first quarter 2026 revenue guidance of
$1.05 0 billion to$1.09 0 billion with GAAP diluted EPS of$1.40 t o$1.55 , including$0.26 of stock-based compensation expense. Fiscal first quarter non-GAAP EPS guidance of$1.66 t o$1.81 excludes stock-based compensation expense.
Three Months Ended | ||||||
Sep 27, 2025 | Sep 27, 2025 | Jan 3, 2026 | ||||
Q4F25 Results | Q4F25 Guidance | Q1F26 Guidance | ||||
Summary GAAP Items | ||||||
Revenue (in billions) | ||||||
Operating margin | ||||||
Diluted EPS | ||||||
Summary Non-GAAP Items (1) | ||||||
Adjusted operating margin (2) | ||||||
Adjusted EPS (3) | ||||||
Return on invested capital (ROIC) | ||||||
Economic return | ||||||
(1) | Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures. | |||||
(2) | Excludes stock-based compensation expense of approximately 80 bps for Q4F25 results as well as 70 bps for Q4F25 guidance and Q1F26 guidance. | |||||
(3) | Excludes stock-based compensation expense, net of tax, of | |||||
Fiscal Fourth Quarter 2025 Information
- Won 28 manufacturing programs representing
$274 million in annualized revenue when fully ramped into production. - Generated free cash flow of
$97 million . - Purchased
$21.5 million of our shares at an average price of$134.07 per share under our share repurchase programs. Under our current$100.0 million repurchase authorization,$85.0 million remains available.
Fiscal Year 2025 Information
- Generated free cash flow of
$154 million . - Produced ROIC of
14.6% , representing an economic return of 570 basis points above our weighted average cost of capital of8.9% . - Purchased
$65.0 million of our shares at an average price of$136.80 per share.
Todd Kelsey, President and Chief Executive Officer, commented, “The Plexus team continues to deliver a differentiated value proposition for our customers, and generated strong fiscal fourth quarter results. I am particularly pleased with our non-GAAP EPS of
Mr. Kelsey continued, “Our go-to-market team generated 28 fiscal fourth quarter manufacturing wins, representing
Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, "For the seventh consecutive quarter, our team drove a reduction in our gross inventory balance, ending the fiscal year
Mr. Jermain continued, "We delivered
Mr. Kelsey added, “We remain dedicated to our Plexus Value of Innovating Responsibly to help create the products that build a better world. For fiscal 2025, our global team contributed more than 32,000 paid volunteer hours to our local communities, a
Mr. Kelsey continued, “We are guiding fiscal first quarter revenue of
Mr. Kelsey concluded, “Fiscal 2025 was an outstanding year for Plexus. Our team delivered excellent operational execution, strong financial performance, including 40 basis points of non-GAAP operating margin expansion and
Quarterly & Annual Comparison | Three Months Ended | Twelve Months Ended | |||||||||||||||||
(in thousands, except EPS) | Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 | Sep 27, 2025 | Sep 28, 2024 | ||||||||||||||
Revenue | $ | 1,058,366 | $ | 1,018,308 | $ | 1,050,569 | $ | 4,032,966 | $ | 3,960,827 | |||||||||
Gross profit | 104,783 | 103,288 | 107,912 | 406,514 | 378,530 | ||||||||||||||
Operating income | 53,112 | 53,608 | 53,858 | 202,371 | 167,732 | ||||||||||||||
Net income | 51,429 | 45,116 | 41,221 | 172,885 | 111,815 | ||||||||||||||
Diluted EPS | $ | 1.87 | $ | 1.64 | $ | 1.48 | $ | 6.26 | $ | 4.01 | |||||||||
Gross margin | 9.9 | % | 10.1 | % | 10.3 | % | 10.1 | % | 9.6 | % | |||||||||
Operating margin | 5.0 | % | 5.3 | % | 5.1 | % | 5.0 | % | 4.2 | % | |||||||||
ROIC (1) | 14.6 | % | 14.1 | % | 11.8 | % | 14.6 | % | 11.8 | % | |||||||||
Economic return (1) | 5.7 | % | 5.2 | % | 3.6 | % | 5.7 | % | 3.6 | % | |||||||||
(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return. | |||||||||||||||||||
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised
Business Segments ($ in millions) | Three Months Ended | Twelve Months Ended | |||||||||||||||||
Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 | Sep 27, 2025 | Sep 28, 2024 | |||||||||||||||
Americas | $ | 336 | $ | 312 | $ | 307 | $ | 1,217 | $ | 1,219 | |||||||||
Asia-Pacific | 605 | 594 | 618 | 2,393 | 2,213 | ||||||||||||||
Europe, Middle East and Africa | 119 | 117 | 128 | 440 | 538 | ||||||||||||||
Elimination of inter-segment sales | (2 | ) | (5 | ) | (2 | ) | (17 | ) | (9 | ) | |||||||||
Total Revenue | $ | 1,058 | $ | 1,018 | $ | 1,051 | $ | 4,033 | $ | 3,961 | |||||||||
Market Sectors ($ in millions) | Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 | Sep 27, 2025 | Sep 28, 2024 | ||||||||||||||||||||
Aerospace/Defense | $ | 173 | 16 | % | $ | 183 | 18 | % | $ | 184 | 18 | % | $ | 689 | 17 | % | $ | 698 | 19 | % | ||||
Healthcare/Life Sciences | 424 | 40 | % | 420 | 41 | % | 415 | 39 | % | 1,629 | 40 | % | 1,555 | 38 | % | |||||||||
Industrial | 461 | 44 | % | 415 | 41 | % | 452 | 43 | % | 1,715 | 43 | % | 1,708 | 43 | % | |||||||||
Total Revenue | $ | 1,058 | $ | 1,018 | $ | 1,051 | $ | 4,033 | $ | 3,961 | ||||||||||||||
Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.
ROIC and Economic Return
ROIC for fiscal year 2025 was
Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended September 27, 2025, cash flows provided by operations was
Cash Cycle Days | Three Months Ended | |||||
Sep 27, 2025 | Jun 28, 2025 | Sep 28, 2024 | ||||
Days in Accounts Receivable | 57 | 59 | 54 | |||
Days in Contract Assets | 13 | 13 | 10 | |||
Days in Inventory | 118 | 128 | 127 | |||
Days in Accounts Payable | (70) | (72) | (59) | |||
Days in Advanced Payments | (55) | (59) | (68) | |||
Annualized Cash Cycle (1) | 63 | 69 | 64 | |||
(1) | Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments. | |||||
Conference Call and Webcast Information
What: | Plexus Fiscal Q4 and Fiscal Year 2025 Earnings Conference Call and Webcast |
When: | Thursday, October 23, 2025 at 8:30 a.m. Eastern Time |
Where: | Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below: Webcast link: https://events.q4inc.com/attendee/727582481 |
Replay: | The webcast will be archived on the Plexus website and will be available as on-demand for 12 months |
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
Since 1979, Plexus has helped create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. For more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2024 Form 10-K.
PLEXUS CORP. AND SUBSIDIARIES | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
(in thousands, except per share data) | |||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||
Sep 27, | Sep 28, | Sep 27, | Sep 28, | ||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||
Net sales | $ | 1,058,366 | $ | 1,050,569 | $ | 4,032,966 | $ | 3,960,827 | |||||||
Cost of sales | 953,583 | 942,657 | 3,626,452 | 3,582,297 | |||||||||||
Gross profit | 104,783 | 107,912 | 406,514 | 378,530 | |||||||||||
Operating expenses: | |||||||||||||||
Selling and administrative expenses | 51,671 | 54,054 | 199,460 | 190,541 | |||||||||||
Restructuring and other charges, net | — | — | 4,683 | 20,257 | |||||||||||
Operating income | 53,112 | 53,858 | 202,371 | 167,732 | |||||||||||
Other income (expense): | |||||||||||||||
Interest expense | (2,413 | ) | (5,577 | ) | (11,605 | ) | (28,876 | ) | |||||||
Interest income | 883 | 1,220 | 3,922 | 3,860 | |||||||||||
Miscellaneous, net | (1,917 | ) | (4,087 | ) | (6,670 | ) | (13,184 | ) | |||||||
Income before income taxes | 49,665 | 45,414 | 188,018 | 129,532 | |||||||||||
Income tax (benefit) expense | (1,764 | ) | 4,193 | 15,133 | 17,717 | ||||||||||
Net income | $ | 51,429 | $ | 41,221 | $ | 172,885 | $ | 111,815 | |||||||
Earnings per share: | |||||||||||||||
Basic | $ | 1.91 | $ | 1.52 | $ | 6.39 | $ | 4.08 | |||||||
Diluted | $ | 1.87 | $ | 1.48 | $ | 6.26 | $ | 4.01 | |||||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 26,901 | 27,203 | 27,038 | 27,397 | |||||||||||
Diluted | 27,444 | 27,783 | 27,616 | 27,909 | |||||||||||
PLEXUS CORP. AND SUBSIDIARIES | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(in thousands, except per share data) | |||||||
(unaudited) | |||||||
Sep 27, | Sep 28, | ||||||
2025 | 2024 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 306,464 | $ | 345,109 | |||
Restricted cash | 294 | 2,353 | |||||
Accounts receivable | 656,573 | 622,366 | |||||
Contract assets | 150,654 | 120,560 | |||||
Inventories | 1,229,839 | 1,311,434 | |||||
Prepaid expenses and other | 54,969 | 75,328 | |||||
Total current assets | 2,398,793 | 2,477,150 | |||||
Property, plant and equipment, net | 546,052 | 501,112 | |||||
Operating lease right-of-use assets | 72,863 | 74,360 | |||||
Deferred income taxes | 91,349 | 73,919 | |||||
Other assets | 28,053 | 27,280 | |||||
Total non-current assets | 738,317 | 676,671 | |||||
Total assets | $ | 3,137,110 | $ | 3,153,821 | |||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Current portion of long-term debt and finance lease obligations | $ | 45,793 | $ | 157,325 | |||
Accounts payable | 726,597 | 606,378 | |||||
Advanced payments from customers | 575,850 | 709,152 | |||||
Accrued salaries and wages | 109,076 | 94,448 | |||||
Other accrued liabilities | 61,367 | 75,991 | |||||
Total current liabilities | 1,518,683 | 1,643,294 | |||||
Long-term debt and finance lease obligations, net of current portion | 91,987 | 89,993 | |||||
Accrued income taxes payable | — | 17,198 | |||||
Long-term operating lease liabilities | 29,422 | 32,275 | |||||
Deferred income taxes | 6,000 | 8,234 | |||||
Other liabilities | 36,430 | 38,002 | |||||
Total non-current liabilities | 163,839 | 185,702 | |||||
Total liabilities | 1,682,522 | 1,828,996 | |||||
Shareholders’ equity: | |||||||
Common stock | 547 | 545 | |||||
Additional paid-in-capital | 695,653 | 680,638 | |||||
Common stock held in treasury | (1,255,451 | ) | (1,190,115 | ) | |||
Retained earnings | 1,996,028 | 1,823,143 | |||||
Accumulated other comprehensive income | 17,811 | 10,614 | |||||
Total shareholders’ equity | 1,454,588 | 1,324,825 | |||||
Total liabilities and shareholders’ equity | $ | 3,137,110 | $ | 3,153,821 | |||
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 1 | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||||||
Sep 27, | Jun 28, | Sep 28, | Sep 27, | Sep 28, | ||||||||||||||||
2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
Operating income, as reported | $ | 53,112 | $ | 53,608 | $ | 53,858 | $ | 202,371 | $ | 167,732 | ||||||||||
Operating margin, as reported | 5.0 | % | 5.3 | % | 5.1 | % | 5.0 | % | 4.2 | % | ||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Restructuring costs (1) | — | — | — | 4,683 | 22,507 | |||||||||||||||
Other non-recurring income (2) | — | — | — | — | (2,250 | ) | ||||||||||||||
Stock-based compensation | 7,803 | 7,691 | 10,849 | 29,616 | 30,485 | |||||||||||||||
Non-GAAP operating income | $ | 60,915 | $ | 61,299 | $ | 64,707 | $ | 236,670 | $ | 218,474 | ||||||||||
Non-GAAP operating margin | 5.8 | % | 6.0 | % | 6.2 | % | 5.9 | % | 5.5 | % | ||||||||||
Net income, as reported | $ | 51,429 | $ | 45,116 | $ | 41,221 | $ | 172,885 | $ | 111,815 | ||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Restructuring costs, net of tax (1) | — | — | — | 4,191 | 20,144 | |||||||||||||||
Other non-recurring income, net of tax (2) | — | — | — | — | (2,014 | ) | ||||||||||||||
Stock-based compensation, net of tax | 7,414 | 7,307 | 10,306 | 28,136 | 29,582 | |||||||||||||||
Adjusted net income | $ | 58,843 | $ | 52,423 | $ | 51,527 | $ | 205,212 | $ | 159,527 | ||||||||||
Diluted earnings per share, as reported | $ | 1.87 | $ | 1.64 | $ | 1.48 | $ | 6.26 | $ | 4.01 | ||||||||||
Non-GAAP per share adjustments: | ||||||||||||||||||||
Restructuring costs, net of tax (1) | — | — | — | 0.15 | 0.72 | |||||||||||||||
Other non-recurring income, net of tax (2) | — | — | — | — | (0.07 | ) | ||||||||||||||
Stock-based compensation, net of tax | 0.27 | 0.26 | 0.37 | 1.02 | 1.06 | |||||||||||||||
Adjusted diluted earnings per share | $ | 2.14 | $ | 1.90 | $ | 1.85 | $ | 7.43 | $ | 5.72 |
(1) | During the twelve months endedSeptember 27, 2025, restructuring costs of During the twelve months ended September 28, 2024, restructuring costs of |
(2) | During the twelve months ended September 28, 2024, insurance proceeds of |
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 2 | ||||||||||||||
(in thousands) | ||||||||||||||
(unaudited) | ||||||||||||||
ROIC and Economic Return Calculations | Twelve Months Ended | Nine Months Ended | Twelve Months Ended | |||||||||||
Sep 27, | Jun 28, | Sep 28, | ||||||||||||
2025 | 2025 | 2024 | ||||||||||||
Operating income, as reported | $ | 202,371 | $ | 149,259 | $ | 167,732 | ||||||||
Restructuring and other charges, net | 4,683 | 4,683 | 20,257 | |||||||||||
Accelerated stock-based compensation (1) | + | — | + | — | + | 5,063 | ||||||||
Adjusted operating income | $ | 207,054 | $ | 153,942 | $ | 193,052 | ||||||||
÷ | 3 | |||||||||||||
$ | 51,314 | |||||||||||||
x | 4 | |||||||||||||
Adjusted annualized operating income | $ | 207,054 | $ | 205,256 | $ | 193,052 | ||||||||
Adjusted effective tax rate | x | 8 | % | x | 11 | % | x | 13 | % | |||||
Tax impact | 16,564 | 22,578 | 25,097 | |||||||||||
Adjusted operating income (tax-effected) | $ | 190,490 | $ | 182,678 | $ | 167,955 | ||||||||
Average invested capital | ÷ | $ | 1,303,575 | ÷ | $ | 1,298,575 | ÷ | $ | 1,418,698 | |||||
ROIC | 14.6 | % | 14.1 | % | 11.8 | % | ||||||||
Weighted average cost of capital | - | 8.9 | % | - | 8.9 | % | - | 8.2 | % | |||||
Economic return | 5.7 | % | 5.2 | % | 3.6 | % | ||||||||
Average Invested Capital Calculations | Sep 27, | Jun 28, | Mar 29, | Dec 28, | Sep 28, | ||||||||||||||
2025 | 2025 | 2025 | 2024 | 2024 | |||||||||||||||
Equity | $ | 1,454,588 | $ | 1,419,085 | $ | 1,351,675 | $ | 1,319,069 | $ | 1,324,825 | |||||||||
Plus: | |||||||||||||||||||
Debt and finance lease obligations - current | 45,793 | 50,678 | 121,014 | 121,977 | 157,325 | ||||||||||||||
Operating lease obligations - current (2) | 8,253 | 8,470 | 9,968 | 14,875 | 14,697 | ||||||||||||||
Debt and finance lease obligations - long-term | 91,987 | 92,215 | 88,761 | 88,728 | 89,993 | ||||||||||||||
Operating lease obligations - long-term | 29,422 | 31,192 | 32,720 | 35,124 | 32,275 | ||||||||||||||
Less: Cash and cash equivalents | (306,464 | ) | (237,567 | ) | (310,531 | ) | (317,161 | ) | (345,109 | ) | |||||||||
$ | 1,323,579 | $ | 1,364,073 | $ | 1,293,607 | $ | 1,262,612 | $ | 1,274,006 | ||||||||||
Average Invested Capital Calculations | Jun 29, | Mar 30, | Dec 30, | Sep 30, | |||||||||||
2024 | 2024 | 2023 | 2023 | ||||||||||||
Equity | $ | 1,266,360 | $ | 1,259,762 | $ | 1,266,755 | $ | 1,214,382 | |||||||
Plus: | |||||||||||||||
Debt and finance lease obligations - current | 258,175 | 245,964 | 251,119 | 240,205 | |||||||||||
Operating lease obligations - current (2) | 7,990 | 8,281 | 9,172 | 8,363 | |||||||||||
Debt and finance lease obligations - long-term | 90,715 | 192,025 | 192,118 | 190,853 | |||||||||||
Operating lease obligations - long-term | 31,923 | 33,915 | 35,989 | 38,552 | |||||||||||
Less: Cash and cash equivalents | (269,868 | ) | (265,053 | ) | (231,982 | ) | (256,233 | ) | |||||||
$ | 1,385,295 | $ | 1,474,894 | $ | 1,523,171 | $ | 1,436,122 | ||||||||
(1) | During the twelve months ended September 28, 2024, |
(2) | Included in other accrued liabilities on the Condensed Consolidated Balance Sheets. |
